Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is reporting a full-year net loss of $472 million in 2021, compared to a loss of $560 million the previous year. The company says full-year revenue was $4.7 billion, an increase of 46%.
Elanco also reports a fourth quarter net loss of $97 million, compared to $323 million during the same period a year earlier. Q4 revenue came in at $1.1 billion, a decrease of 2%.
“The fourth quarter of 2021 represents our 5th consecutive quarter of outperforming our expectations,” said Elanco President and Chief Executive Officer Jeff Simmons. “Our diverse portfolio delivered across the business – growing in all three regions and in four out of five species, demonstrating the durable growth profile of our business.”
Simmons expects the company to see two-to-three percent revenue growth. Click here to view the full report.